|
WO2021021765A1
|
|
Nutritive compositions with bioactive proteins
|
|
WO2021021746A1
|
|
NUTRITIVE COMPOSITIONS WITH SECRETED IgA, MILK FAT GLOBULE MEMBRANE COMPONENTS AND/OR BIFIDOBACTERIUM
|
|
WO2020142755A1
|
|
Diagnosis and treatment of dysbiosis-associated with nec
|
|
WO2019246316A1
|
|
Novel oligosaccharides for use in prebiotic applications
|
|
SG11202011817WA
|
|
Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
|
|
SG11202011820VA
|
|
Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
|
|
US2020345055A1
|
|
Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains
|
|
US2020385777A1
|
|
Method for determining dysbiosis in the intestinal microbiome
|
|
US2020206732A1
|
|
Methods and apparatus for collecting and testing solid or semi-solid materials
|
|
US2021069268A1
|
|
Metabolomic revision of mammalian infants
|
|
WO2019055717A1
|
|
Oligosaccharide compositions and their use during transitional phases of the mammalian gut microbiome
|
|
MX2018015725A
|
|
Method for facilitating maturation of the mammalian immune system.
|
|
BR112018068261A2
|
|
transient commensal microorganism to improve bowel health
|
|
US2019069586A1
|
|
Food Compositions for Weaning
|
|
WO2016168729A1
|
|
Delivering non-pathogenic, intestinally beneficial bacteria to a patient having a feeding tube
|
|
SG10202002010VA
|
|
Compositions that metabolize or sequester free sugar monomers and uses thereof
|
|
US2018267037A1
|
|
Method for the noninvasive detection of activated bifidobacteria
|
|
CN107249611A
|
|
The Bifidobacterium of activation and its application process
|
